To encourage a patient-centric environment, virtual clinical trials do have the ability to foster significant digital changes in clinical research methodologies. These solutions use many of the benefits of technology, like advanced apps, electronic gadgets, social networking engagement platforms, artificial intelligence, automated robotics, and machine learning, among other things. Over the past few years, Veristat virtual clinical trials have changed a lot thanks to clinical trial consulting, digitalization, and better technology. Virtual, remote, or decentralized solutions for clinical trials add value to the whole trial process, from planning to data analysis to reporting. Here’s how
Virtual trials are patient-centric
Virtual clinical trials save time and money, and they can be done in the patient’s own home. Patients who have trouble moving around are also given a break and find it easier to take part in virtual trials. Patients can take part in virtual clinical trials from the comfort of their own homes, even if they can’t move around. This makes them more likely to take part and makes it easier for doctors and trial staff to reach a larger number of patients.
When the pandemic started, it made it harder to keep going with clinical trials. Rapid adaptation strategies were developed to keep them credible and active. Social networking, AI, and remote patient monitoring are all examples of data-driven solutions that have been shown to work. Trial continuity is dependent on both technology and adaptability. Other important parts of keeping a trial going will even depend on things like training, care during treatment, and outside factors (i.e., the internet and remote devices). Direct contact with the patient, in-home help or nursing, and making sure the home is safe and has enough resources and power can all be used to solve these problems.
Improved data collection
Improved data collection is another benefit of decentralized virtual trials. Effective data management tools are in greater demand as these studies gain popularity. Virtual trials are becoming more common, and you can think of them as a new way to gather data that works well. The study can also have shorter deadlines, better safety evaluations, and new endpoints and metrics, in addition to better data collection. The patient retains ownership of the real-time data that the device collects, which can be shared with clinical professionals at any time for analysis. Drug profiles can be predicted using digital data obtained throughout trials.
Better treatment and patient experience
Most patients like being able to participate remotely. It adds a level of ease that would be impossible without it. They also don’t have to deal with the hassles of getting trial data, such as transportation. Data show a general improvement in patient experience and conformance to trial goals.
Help relieve pressure on trial sites
Virtual trials are appealing because there is a lot of competition for trial sites, and late-phase studies add to their workload. Patients are more likely to stick with a trial and comply with its requirements if data collection takes place in their homes at times that are convenient for them. As part of their support for virtual trials, sponsors should work with CROs or technology providers to make sure that patients can easily use the technology and that the data generated is correct.
In the last few years, virtual clinical trials have undergone tremendous change. As a result, holding a virtual trial has multiple benefits. They include enhanced patient engagement, cost reductions, improved data capture, and empowered researchers.